Not applicableUnknownNCT04528940What this trial is testingTumor Grade Determines PD-1/PDL-1 ExpressionWho this might be right forEndometrial CancerOvarian Cancer RWJ Barnabas Health at Jersey City Medical Center 100
Post-approval studies (Phase 4)Study completedNCT00795808What this trial is testingPCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With ClomipheneWho this might be right forPolycystic Ovary Syndrome University of Auckland, New Zealand 171
Testing effectiveness (Phase 2)Study completedNCT06087289What this trial is testingEvaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forEpithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer Novakand Pharma AB 18
Early research (Phase 1)Looking for participantsNCT06885697What this trial is testingAnti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaWho this might be right forMesotheliomaNeoplasmsStomach Neoplasms+5 more National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)Ended earlyNCT03933813What this trial is testingEvaluation and Treatment of Iron Deficiency in Ovarian Cancer PatientsWho this might be right forEpithelial Ovarian CancerAnemiaIron Deficiency Anemia University of Wisconsin, Madison 9
Early research (Phase 1)Study completedNCT02146313What this trial is testingA Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic CancerWho this might be right forPancreatic NeoplasmsOvarian Neoplasms Genentech, Inc. 35
Early research (Phase 1)Ended earlyNCT00637390What this trial is testingA Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.Who this might be right forOvarian CancerFallopian Tube CancerPeritoneal Cancer University of Michigan Rogel Cancer Center 3
Not applicableStudy completedNCT00340210What this trial is testingExtended Follow-up of Columbia, MO Serum Bank ParticipantsWho this might be right forBreast CancerEndometrial CancerOvarian Cancer National Cancer Institute (NCI) 6,720
Not applicableLooking for participantsNCT06392997What this trial is testingEvaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic PathologyWho this might be right forGynecologic DiseaseGynecologic CancerEndometriosis+5 more ZIWIG 2,500
Testing effectiveness (Phase 2)Study completedNCT01001910What this trial is testingPemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma Albert Einstein College of Medicine 22
Large-scale testing (Phase 3)Study completedNCT00262990What this trial is testingPatupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal CancerWho this might be right forOvarian CancerFallopian Tube CancerPeritoneal Neoplasms Novartis Pharmaceuticals 829
Large-scale testing (Phase 3)Not Yet RecruitingNCT07550205What this trial is testingTiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian CancerWho this might be right forOvarian Neoplasms MalignantSleep Initiation and Maintenance DisordersMedicine, Chinese Traditional+2 more Shanghai Municipal Hospital of Traditional Chinese Medicine 360
Testing effectiveness (Phase 2)Ended earlyNCT00331422What this trial is testingCarboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer Masonic Cancer Center, University of Minnesota 7
Early research (Phase 1)Ended earlyNCT05061537What this trial is testingStudy of PF-07263689 in Participants With Selected Advanced Solid TumorsWho this might be right forRenal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more Pfizer 13
Early research (Phase 1)Study completedNCT01975831What this trial is testingEvaluate MEDI4736 in Combination With TremelimumabWho this might be right forBreast CancerOvarian CancerColorectal Cancer+2 more Ludwig Institute for Cancer Research 104
Not applicableStudy completedNCT00488202What this trial is testingAdvanced Ovarian Cancer and Sexuality Phase 1Who this might be right forOvarian CancerSexual Function University of British Columbia 26
Post-approval studies (Phase 4)UnknownNCT01631253What this trial is testingThe Impact on Ovarian Reserve After Single-port, Two-port, or Four-port Access Laparoscopic Ovarian Cyst EnucleationWho this might be right forOvarian Cyst CHA University 90
Testing effectiveness (Phase 2)Ended earlyNCT04377087What this trial is testingDelayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian CancerWho this might be right forOvarian Cancer Sarah E Taylor 3
Early research (Phase 1)Ended earlyNCT06466187What this trial is testingSGN-MesoC2 in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more Seagen, a wholly owned subsidiary of Pfizer 19
Not applicableEnded earlyNCT01744821What this trial is testingVitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal CancerWho this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Cancer Northwestern University 7